Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2 participants
OBSERVATIONAL
2020-01-22
2020-02-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Developing Advanced Neuroimaging for Clinical Evaluation of Autoimmune Encephalitis
NCT05280600
BRIEF TITLE * (in English and Sufficiently Descriptive) Role of MRI in Anti-LGI1 Encephalitis
NCT05825690
HLA Analysis in Autoimmune Encephalitis and Related Disorders: Part II
NCT04823728
Characterization of Immune-response in Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes
NCT05772611
HLA Analysis in Autoimmune Encephalitis and Related Disorders
NCT04106596
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Patients in the study group have a diagnosis of autoimmune encephalitis, are 18 to 70 years old, and have no significant comorbidity such as psychiatric, neurological conditions and able to understand the aim of this study.
oculomotor movement recordings, neurovisual assessment
Each participant will have a neurovisual assessment and an oculomotor movement recording with an eye tracker (infra red cameras).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
oculomotor movement recordings, neurovisual assessment
Each participant will have a neurovisual assessment and an oculomotor movement recording with an eye tracker (infra red cameras).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* With or without pathological antibody
* Aged from 18 to 70 years old
* Able to understand the aims and methods of this project
* Non opposed to the participation of this study
Exclusion Criteria
* Ophthalmological condition, which could modify the interpretation of neuro-ophthalmological data Inability to remain seated
* Pregnancy or breast feeding
* Adults under guardianship
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Caroline Tilikete, Prof.
Role: PRINCIPAL_INVESTIGATOR
Department of neuro-ophthalmology, Pierre Wertheimer university hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospices Civils de Lyon
Bron, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-A00684-53
Identifier Type: OTHER
Identifier Source: secondary_id
69HCL18_0749
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.